1Department of Health. Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. Report on Health and Social Subjects No. 41. London: HMSO, 1991; 161–6.
2Buttriss, J, Hughes, J. A review of the MAFF optimal nutrition status programme. BNF Nutr. Bull. 2000; 25(1): 79–80.
3Buttriss, J, Bundy, R, Hughes, J. An update of vitamin K: contribution of MAFF-funded research. BNF Nutr. Bull. 2000; 25(2): 125–34.
4Hughes, J, Buttriss, J. An update on folate and folic acid: contribution of MAFF-funded research. BNF Nutr. Bull. 2000; 25(1): 113–34.
5Hughes, J, Buttriss, J. An update on copper: contribution of MAFF-funded research. BNF Nutr. Bull. 2000; 25(4): 271–80.
6Bellamy, MF, McDowell, IFW. Putative mechanisms for vascular damage by homocysteine. J. Inherited Metab. Disord. 1996; 20: 307–15.
7McDowell, IFW, Ashfield-Watt, P. Approaches to defining optimal folate intake for cardiovascular health. Nutr. Food Sci. 1997; 6: 215–7.
8Bellamy, MF, McDowell, IF, Ramsey, MW, Brownlee, M, Bones, C, Newcombe, RG, Lewis, MJ. Hyperhomocysteinaemia after an oral methionine load acutely impairs endothelial function in healthy subjects. Circulation 1998; 98: 1848–52.
9Still, RA, McDowell, IFW. Clinical implications of plasma homocysteine measurement in cardiovascular disease. J. Clin. Pathol. 1998; 51: 183–8.
10Bellamy, MF, McDowell, IFW, Ramsey, MW, Brownlee, M, Newcombe, RG, Lewis, MJ. Oral folate enhances endothelial function in hyperhomocysteinaemic subjects. Eur. J. Clin. Invest. 1999; 29: 659–62.
11McDowell, IFW. Homocysteine and cardiovascular disease. J. Int. Fed. Clin. Chem. 1998; 10: 73–6.
12Doshi, SN, Goodfellow, J, Lewis, MJ, McDowell, IF. Homocysteine and endothelial function. Cardiovasc Res. 1999; 42: 578–82.
13McNulty, H. Folate requirements for health in different population groups. Br. J. Biomed. Sci. 1995; 52: 110–9.
14McNulty, H. Folate requirements for health in women. Proc. Nutr. Soc. 1997; 56: 291–303.
15Moat, SJ, Bonham, JR, Powers, HJ. Circulating antioxidant enzyme activity is influenced by homocysteine. Netherlands J. Med. 1998; 52: S58.
16Ashfield-Watt, PAL, Knowles, RM, Cale, SB, Clark, ZE, McDowell, IFW. A practical dietary intervention lowers plasma homocysteine in hyperlipidaemic patients. Heart 1999; 81(Suppl. 1): 30.
17Finglas, PM, Wigertz, K, Vahteristo, L, Witthoft, CM, Southon, S, de Froidmont-Gortz, I. Standardisation of HPLC procedures for the determination of naturally-occurring folates in food. Food Chem. 1999; 64: 245–55.
18Cuskelly, GJ, McNulty, H, Scott, JM. Low levels of folic acid fortification make a significant difference in folate status in young women: implications for the prevention of neural tube defects. Am. J. Clin. Nutr. 1999; 70: 234–9.
19McNulty, H, Cuskelly, GJ, Ward, M. Response of red cell folates to intervention: implications for folate recommendations for the prevention of neural tube defects. Am. J. Clin. Nutr. 2000; 71(5): 1308S–11S.
20Department of Health. Folic Acid and the Prevention of Disease. Report on Health and Social Subjects No. 50. London: HMSO, 2000.
21Gregory, J, Foster, K, Tyler, H, Wiseman, M. The Dietary and Nutritional Survey of British Adults. London: HMSO, 1990.
22Ministry of Agriculture, Fisheries and Food (MAFF). National Food Survey. London: HMSO, 1998.
23Scott, JM. Folate and vitamin B12. Proc. Nutr. Soc. 1999; 58: 441–8.
24Scott, JM, Weir, DG. Folic acid, homocysteine and one-carbon metabolism: a review of the essential biochemistry. J. Cardiovasc. Risk 1998; 5(4): 223–7.
25Graham, IM, Daly, LE, Refsum, HM, Robinson, K, Brattstrom, LE, Ueland, PM, Palma-Reis, RJ, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. J. Am. Med. Assoc. 1997; 277: 1775–81.
26Selhub, J, Jacques, PF, Wilson, PW, Rush, D, Rosenberg, IH. Vitamin status and intake as primary determinants of homocysteine in an elderly population. J. Am. Med. Assoc. 1993; 270: 2693–8.
27Clarke, R. Homocysteine and cardiovascular disease. Overview. J. Cardiovasc. Risk 1998; 5(4): 213–5.
28Clarke, R, Collins, R. Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test homocysteine hypothesis of vascular disease. J. Cardiovasc. Risk 1998; 5(4): 249–55.
29Weisberg, T, Tran, P, Christensen, B, Sibani, S, Rozen, R. A second genetic polymorphism in methylenetetrahydofolate reductase (MTHFR) associated with decreased enzyme activity. Mol. Genet. Metab. 1998; 64(3): 169–72.
30Freudenheim, JL, Marshall, JR, Vena, JE, Laughlin, R, Brasure, JR, Swanson, MK, Nemoto, T, Graham, S. Premenopausal breast cancer risk and intake of vegetables, fruits, and related nutrients. J. Natl. Cancer Inst. 1996; 88(6): 340–8.
31Clarke, R, Smith, AD, Jobst, KA, Refsum, H, Sutton, L, Ueland, PM. Folate, vitamin B12 and serum total homocysteine levels in confirmed Alzheimer disease. Arch. Neurol. 1998; 55: 1449–55.
32Kelly, P, McPartlin, J, Goggins, M, Weir, DG, Scott, JM. Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am. J. Clin. Nutr. 1997; 65(6): 1790–5.
33Sweeney, MR, McPartlin, J, Weir, DG, Scott, JM. Folic acid fortification of bread: effect of chronic consumption on unmetabolised folic acid in serum. Proc. Nutr. Soc. 2000; 59(OCA): 82A.
34Bates, CJ, Mansoor, MA, van der Pols, J, Prentice, A, Cole, TJ, Finch, S. Plasma total homocysteine in a representative sample of 972 British men and women aged 65 and over. Eur. J. Clin. Nutr. 1997; 51(10): 691–7.
35Harvey, L, Majsak-Newman, G, Fairweather-Tait, SJ, Baker, A, Cachman, K, Flynn, A, Lewis, D, Crewes, H. Effect of dietary copper intake on biochemical indices associated with copper metabolism. In: Roussel, AM, Anderson, RA, Favier, AE, eds. Proceedings of the Tenth International Symposium on Trace Elements in Man and AnimalEvian, France2–7 May 1999. New York: Kluwer Academic/Plenum Publishers, 2000; 959–60.
36Turley, E, McKeown, A, Harvey, LJ, Fairweather-Tait, SJ, Crewes, HM, Strain, JJ. Assessing copper status – a review. Nutr. Food Sci. 1997; 6: 229–32.
37Fairweather-Tait, SJ. Bioavailability of copper. Eur. J. Clin. Nutr. 1997; 51(Suppl. 1): 24S–6S.
38Crews, HM, Baxter, MJ, Lewis, DJ, Havermeister, W, Fairweather-Tait, SJ, Harvey, LJ, Majsak-Newman, G. Multi-element and isotope ratio determinations in foods and clinical samples using inductively coupled plasma–mass spectrometry. In: Trace Elements in Man and Animals – 9. Ottawa, Canada: NRC Research Press, 1997.
39Lewis, AJ. The role of copper in inflammatory disorders. Agents Actions 1984; 15: 513–9.
40Rock, A, Mazur, A, Rayssiguier, Y, Kehoe, C, O'Connor, JM, Bonham, MP, Strain, JJ. Effect of copper supplementation in middle aged people on plasma anti-oxidants and red blood cell oxidizability: FOODCUE Study. In: Roussel, AM, Anderson, RA, Favier, AE, eds. Proceedings of the Tenth International Symposium on Trace Elements in Man and AnimalEvian, France2–7 May 1999. New York: Kluwer Academic/Plenum Publishers, 2000; 475–6.
41Olivares, M, Uauy, R. Copper as an essential nutrient. Am. J. Clin. Nutr. 1996; 63: 791S–6S.
42Ministry of Agriculture, Fisheries and Food (MAFF). 1994 Total Diet Study: Metals and Other Elements. Food Surveillance Information Sheet No. 131. London: MAFF, 1997.
43Gregory, J, Lowe, S, Bates, CJ, Prentice, A, Jackson, LV, Smithers, G, Wenlock, R, Farron, M. National Diet and Nutrition Survey: Young People aged 4 to 18 years. London: The Stationery Office, 2000.
44Gibson, RS. Content and bioavailability of trace elements in vegetarian diets. Am. J. Clin. Nutr. 1984; 59: 1223S–32S.
45Ministry of Agriculture, Fisheries and Food (MAFF). Duplicate Diet Study of Vegetarians – Dietary Exposure to 12 Metals and Other Elements. Food Surveillance Information Sheet No. 193. London: MAFF, 2001.
46Lonnerdal, B, Keen, CL. New functions of trace elements. Scand. J. Nutr. 1999; 43(Suppl. 2): 25S–6S.
47Strain, JJ. Defining optimal copper status in humans. Concepts and problems. In: Roussel, AM, Anderson, RA, Favier, AE, eds. Proceedings of the Tenth International Symposium on Trace Elements in Man and AnimalEvian, France2–7 May 1999. New York: Kluwer Academic/Plenum Publishers, 2000; 923–8.
48National Research Council. Recommended Dietary Allowances. Washington, DC: National Academy Press, 1989.
49Lund, EK, Wharf, SG, Fairweather-Tait, SJ, Johnson, IT. Oral ferrous sulfate supplements increase the free radical-generating capacity of feces from healthy volunteers. Am. J. Clin. Nutr. 1999; 69(2): 250–5.
50Rehman, A, Collis, CS, Yang, M, Kelly, M, Diplock, AT, Halliwell, B, Rice-Evans, C. The effects of iron and vitamin C co-supplementation on oxidative damage to DNA in healthy volunteers. Biochem. Biophys. Res. Commun. 1998; 246(1): 293–8.
51Fairweather-Tait, SJ, Johnson, IT, Wharf, SG, Lund, EK. Iron – getting the balance right. Nutr. Food Sci. 1997; 6: 212–4
52Lund, EK, Wharf, SJ, Fairweather-Tait, SJ, Johnson, IT. The effects of dietary iron and phytate on cell proliferation and apotosis in rat large intestine. Gut 1996; 38(Suppl. 1): A19.
53Wharf, SG, Lund, EK, Parker, M, Johnson, IT, Fairweather-Tait, SJ. The feasibility of using exfoliated human colon cells to monitor the potential pro-oxidant effects of iron. In: Trace Elements in Man and Animals – 9. Ottawa, Canada: NRC Research Press, 1997.
54Collis, CS, Yang, M, Peach, SJ, Diplock, AT, Rice-Evans, C. The effects of ascorbic acid and iron cosupplementation on the proliferation of 3T3 fibroblasts. Free Radical Res. 1996; 25: 87–93.
55Southon, S, Wright, AJA, Finglas, PM, Bailey, AL, Loughridge, JM, Walker, AD. Dietary intake and micronutrient status of adolescents: effect of vitamin and trace element supplementation on indices of status and performance in tests of verbal and non-verbal intelligence. Br. J. Nutr. 1994; 71: 897–918.
56Fairweather-Tait, SJ, Minihane, AM, Eagles, J, Owen, L, Crews, HM. Rare earth elements as nonabsorbable fecal markers in studies of iron absorption. Am. J. Clin. Nutr. 1997; 65(4): 970–6.
57British Nutrition Foundation. Iron: Nutritional and Physiological Significance. London: Chapman & Hall, 1995.
58De Andraca, I, Castillo, M, Walter, T. Psychomotor development and behavior in iron-deficient anemic infants. Nutr. Rev. 1997; 55: 125–32.
59Oski, FA, Honig, AS, Helu, B, Howanitz, P. Effect of iron therapy on behavior performance in nonanemic, iron-deficient infants. Paediatrics 1983; 71: 877–80.
60Beard, J. One person's view of iron deficiency, development, and cognitive function. Am. J. Clin. Nutr. 1995; 62: 709–10.
61Pollitt, E. Iron deficiency and educational deficiency. Nutr. Rev. 1997; 55: 133–41.
62Allen, LH. Pregnancy and iron deficiency: unresolved issues. Nutr. Rev. 1997; 55: 91–101.
63Levin, HM. A benefit–cost analysis of nutritional programs for anaemia reduction. Res Obs. 1986; 1: 219–45.
64Cook, JD. Defining optimal body iron. Proc. Nutr. Soc. 1999; 58: 489–95.
65Babbs, CF. Free radicals and the etiology of colon cancer. Free Radical Biol. Med. 1989; 8: 191–200.
66Weinberg, ED. Roles of iron in neoplasia: promotion, prevention and therapy. Biol. Trace Element Res. 1992; 34: 123–40.
67Tseng, M, Sandler, RS, Greenberg, ER, Mandel, JS, Haile, RW, Baron, JA. Dietary iron and recurrence of colorectal adenomas. Cancer Epidemiol. Biomark. Prev. 1997; 6(12): 1029–32.
68Klausner, RD, Rouault, TA, Harford, JB. Regulating the fate of mRNA: the controls of cellular iron metabolism. Cell 1993; 72: 19–28.
69MacPhail, AP, Charlton, R, Bothwell, TH, Bezwoda, WR. Experimental fortificants. In: Clydesdale, FM, Weimer, KL, eds. Iron Fortification of Foods. New York: Academic Press, 1985; 55–75.
70Hurrell, RF. Bioavailability of iron. Eur. J. Clin. Nutr. 1997; 51(Suppl. 1): S4–S8.
71Gregory, J, Collins, DL, Davies, SW, Hughes, JM, Clarke, PC. National Diet and Nutrition Survey: Children aged 1½ to 4½ years. Vol. 1. Report of the Diet and Nutrition Survey. London: HMSO, 1995.
72Cook, JD, Watson, SS, Simpson, KM, Lipschitz, DA, Skikne, BS. The effect of high ascorbic acid supplementation on body iron stores. Blood 1984; 64: 721–6.
73Hallberg, L, Brune, M, Rossander, L. Effects of ascorbic acid on iron absorption from different types of meals. Studies with ascorbate rich foods and synthetic ascorbic acid given in different amounts with different meals. Hum. Nutr. Appl. Nutr. 1986; 40A: 97–113.
74Baird, IM, Walters, RL, Sutton, DR. Absorption of slow-release iron and effects of ascorbic acid in normal subjects and after partial gastrectomy. Br Med J. 1974; 4: 505–8.
75Levine, M. New concepts in the biology and chemistry of ascorbic acid. N. Engl. J. Med. 1986; 314: 892–902.
76Hunt, JR, Gallagher, SK, Johnson, LK. Effect of ascorbic acid on apparent iron absorption by women with low iron stores. Am. J. Clin. Nutr. 1994; 59: 1381–5.
77Hallberg, L, Rossander-Hulten, L, Brune, M, Gleerup, A. Calcium and iron absorption: mechanism of action and nutritional importance. Eur. J. Clin. Nutr. 1992; 46: 317–27.
78Minihane, AM, Fairweather-Tait, SJ. Effect of calcium supplementation on daily nonheme-iron absorption and long-term iron status. Am. J. Clin. Nutr. 1998; 68(1): 96–102.
79Worwood, M, Thorpe, SJ, Heath, A, Flowers, CH, Cook, JD. Stable lyophilised reagents for the serum ferritin assay. Clin. Lab. Haematol. 1991; 13: 297–305.
80Wurzlemann, JI, Silver, A, Schreinemachers, DM, Sandler, RS, Everson, RB. Iron intake and the risk of colorectal cancer. Cancer Epidemiol. Biomark. Prev. 1996; 5(7): 503–7.